Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression.

Dupuis, Camie; Robert, Arnaud; Gerard, Ludovic; Morelle, Johann; Laterre, Pierre-François; Hantson, Philippe

Dupuis, Camie; Robert, Arnaud; Gerard, Ludovic; Morelle, Johann; Laterre, Pierre-François; Hantson, Philippe.

Afiliación

Dupuis C; Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
Robert A; Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
Gerard L; Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
Morelle J; Division of Nephrology, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
Laterre PF; Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
Hantson P; Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.

Case Rep Anesthesiol ; 2022: 3312306, 2022.

Article en En | MEDLINE | ID: mdl-35310519

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Anesthesiol Año: 2022 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google